Journal
NEUROTOXICITY RESEARCH
Volume 4, Issue 3, Pages 219-223Publisher
SPRINGER
DOI: 10.1080/10298420290023945
Keywords
Oxidative stress; Neurotoxicity; Methionine; Amyloid beta-peptide; Hydrophobic environment
Categories
Funding
- NIH [AG-05119, AG-1086, AG-12423]
Ask authors/readers for more resources
In Alzheimer's disease (AD) brain increased lipid peroxidation is found. Amyloid beta -peptide [A beta (1-42)] induces oxidative stress (including lipid peroxidation) and neurotoxicity, and the single methionine residue (Met35), is important for these properties. In the current study, we tested the hypothesis that removal of Met35 from lipid bilayer would abrogate the oxidative stress and neurotoxic properties of A beta (1-42), i.e. we tested the hypothesis and found that lipid peroxidation initiated by oxidation of the Met35 is an early event in A beta (1-42) neurotoxicity. Substitution of negatively charged aspartic acid for glycine residue 37 is not predicted to bring the Met35 residue out of the hydrophobic lipid bilayer. In this study, we showed that G37D substitution in A beta (1-42) completely abolishes neurotoxic and oxidative processes associated with the parent peptide. This is demonstrated by the lack of cell toxicity and protein oxidation in contrast to the treatment with native A beta (1-42). Additionally, the G37D peptide does not display the aggregation properties that are associated with native A beta as seen in the thioflavin T (ThT) assay and fibril morphology. The results presented in this work are thus consistent with the notion of the importance of methionine 35 of A beta (1-42) in the lipid-initiated oxidative cascade and subsequent neurotoxicity in AD brain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available